|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received September 11, 2003
Revised October 27, 2003
Accepted after revision January 25, 2004
1 Victoria University of Technology
2 Deakin University
* To whom correspondence should be addressed. E-mail: michael.mckenna{at}vu.edu.au.
Characterisation of expression of, and consequently also
the acute exercise effects on
Na+,K+-ATPase isoforms in human
skeletal muscle remains incomplete and were therefore
investigated. Fifteen healthy subjects (eight males,
seven females) performed fatiguing, knee extensor
exercise at ~40% of their maximal work output per
contraction. A vastus lateralis muscle biopsy was taken
at rest, fatigue, 3 and 24 h post-exercise, and analysed
for Na+,K+-ATPase &
[alpha] 1 ,
2 , &
[alpha]3 ,
1 , &
[beta]2 and
3 mRNA and
crude homogenate protein expression, using Real-Time RT-
PCR and immunoblotting, respectively. Each individual
expressed gene transcripts and protein bands for each Na+,K+-ATPase isoforms. Each
isoform was also expressed in a primary human skeletal
muscle cell culture. Intense exercise (352±69 s;
mean±SEM) immediately increased
3 and
2 mRNA by 2.4- and 1.7-fold, respectively (P<0.05), whilst
1 and
2 mRNA were increased by 2.5- and 3.5-fold at 24 h and 3 h post-exercise, respectively (P<0.05). No significant change occurred for
1 and
3 mRNA, reflecting variable time-dependent responses. When the average post-exercise value was contrasted to rest, mRNA increased for all
1-
3,
1-
3 isoforms, by 1.4-, 2.2-, 1.4-, 1.1-, 1.0- and 1.0-fold, respectively (P<0.05). However, exercise did not alter the protein abundance of the
1 -
3 and
1-
3 isoforms.
Thus, human skeletal muscle expresses each of the
Na+,K+-ATPase
1 ,
2 ,
3 ,
1,
2 and
3 isoforms, evidenced at both transcription and protein levels. Whilst brief exercise increased Na+,K+-ATPase isoform mRNA expression, there was no effect on isoform
protein expression, suggesting that the exercise
challenge was insufficient for muscle
Na+,K+-ATPase upregulation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |